Keros Therapeutics, Inc. Common Stock

$12.07
+0.44 (+3.78%)

Volume:

339.709K ($4.10M)

Market Capitalization:

$238.84M

Keros Therapeutics Price Chart

Keros Therapeutics Price Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM12.1112.0211.9311.8311.7411.6511.56

Keros Therapeutics Volume Chart

Keros Therapeutics Volume Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM27.20K23.32K19.43K15.55K11.66K7.77K3.89K

Keros Therapeutics Market Segments

After Hours

+0.00(+0.00%)
Open$12.07
Close$12.07
Low$12.07
Low Change0.00 (0.00%)
High$12.07
High Change+0.00 (+0.00%)
Range$0.00
Volume400
Dollar Volume$4.83K

Regular Trading Hours

+0.46(+3.97%)
Open$11.60
Close$12.06
Low$11.38
Low Change-0.23 (-1.94%)
High$12.11
High Change+0.51 (+4.39%)
Range$0.73
Volume339.309K
Dollar Volume$4.09M

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.10(-0.85%)
Open$11.73
Close$11.63
Low$11.35
Low Change-0.39 (-3.28%)
High$11.74
High Change+0.01 (+0.04%)
Range$0.39
Volume117.808K
Dollar Volume$1.37M

Premarket Yesterday

+0.16(+1.39%)
Open$11.54
Close$11.70
Low$11.54
Low Change0.00 (0.00%)
High$11.70
High Change+0.16 (+1.39%)
Range$0.16
Volume272
Dollar Volume$3.18K

Keros Therapeutics Moving Averages

5 Day Moving Average (SMA5)$11.67
10 Day Moving Average (SMA10)$11.44
20 Day Moving Average (SMA20)$11.47
50 Day Moving Average (SMA50)$11.68
100 Day Moving Average (SMA100)$15.16
200 Day Moving Average (SMA200)$15.49

Keros Therapeutics Statistics

Average Volume (30 Days)341.11K
P/E Ratio (Current)2.68
EPS (Current)$4.40
Dividend Yield0.00%
Free Cash Flow$105.95M
Cash Ratio14.08
Current Ratio15.45
Quick Ratio15.45
Debt to Equity0.00
Enterprise Value-$54.31M
EV to EBITDA-0.79
EV to Sales-0.22
Price to Book0.77
Price to Cash Flow2.17
Price to Free Cash Flow2.20
Price to Sales0.96
Return on Assets0.26%
Return on Equity0.29%

Keros Therapeutics Stock Splits

There have been no stock splits for Keros Therapeutics (KROS).

Keros Therapeutics Dividends

There have been no dividends for Keros Therapeutics (KROS).